• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于口疮病毒(ORFV)的载体表达共识 H1 血凝素可提供针对多种猪流感病毒的保护。

An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses.

机构信息

Department of Population Medicine and Diagnostic Sciences, Animal Health Diagnostic Center, College of Veterinary Medicine, Cornell University, Ithaca, NY 14850, USA.

Department of Animal Sciences, Center for Food Animal Health, College of Food, Agricultural, and Environmental Sciences, The Ohio State University, Wooster, OH 44691, USA.

出版信息

Viruses. 2023 Apr 18;15(4):994. doi: 10.3390/v15040994.

DOI:10.3390/v15040994
PMID:37112974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10147081/
Abstract

Influenza A viruses (IAV-S) belonging to the H1 subtype are endemic in swine worldwide. Antigenic drift and antigenic shift lead to a substantial antigenic diversity in circulating IAV-S strains. As a result, the most commonly used vaccines based on whole inactivated viruses (WIVs) provide low protection against divergent H1 strains due to the mismatch between the vaccine virus strain and the circulating one. Here, a consensus coding sequence of the full-length of HA from H1 subtype was generated in silico after alignment of the sequences from IAV-S isolates obtained from public databases and was delivered to pigs using the Orf virus (ORFV) vector platform. The immunogenicity and protective efficacy of the resulting ORFVconH1 recombinant virus were evaluated against divergent IAV-S strains in piglets. Virus shedding after intranasal/intratracheal challenge with two IAV-S strains was assessed by real-time RT-PCR and virus titration. Viral genome copies and infectious virus load were reduced in nasal secretions of immunized animals. Flow cytometry analysis showed that the frequency of T helper/memory cells, as well as cytotoxic T lymphocytes (CTLs), were significantly higher in the peripheral blood mononuclear cells (PBMCs) of the vaccinated groups compared to unvaccinated animals when they were challenged with a pandemic strain of IAV H1N1 (CA/09). Interestingly, the percentage of T cells was higher in the bronchoalveolar lavage of vaccinated animals in relation to unvaccinated animals in the groups challenged with a H1N1 from the gamma clade (OH/07). In summary, delivery of the consensus HA from the H1 IAV-S subtype by the parapoxvirus ORFV vector decreased shedding of infectious virus and viral load of IAV-S in nasal secretions and induced cellular protective immunity against divergent influenza viruses in swine.

摘要

甲型流感病毒(IAV-S)属于 H1 亚型,在全球范围内在猪中流行。抗原漂移和抗原转变导致循环 IAV-S 株的抗原多样性显著增加。因此,基于全灭活病毒(WIV)的最常用疫苗由于疫苗病毒株与流行株之间的不匹配,对不同的 H1 株提供的保护作用较低。在这里,通过对来自公共数据库的 IAV-S 分离株的序列进行比对,在计算机上生成了 H1 亚型 HA 的全长共识编码序列,并使用口疮病毒(ORFV)载体平台递送给猪。评估了源自 ORFVconH1 重组病毒对仔猪中不同的 IAV-S 株的免疫原性和保护效力。通过实时 RT-PCR 和病毒滴定评估了经鼻腔/气管内攻毒两种 IAV-S 株后的病毒脱落情况。免疫动物鼻腔分泌物中的病毒基因组拷贝数和感染性病毒载量降低。流式细胞术分析表明,与未接种动物相比,当用大流行性 IAV H1N1(CA/09)株攻毒时,接种组外周血单核细胞(PBMC)中的辅助/记忆 T 细胞和细胞毒性 T 淋巴细胞(CTL)的频率明显更高。有趣的是,与未接种动物相比,在接种组用来自伽马分支的 H1N1(OH/07)株攻毒时,接种动物的支气管肺泡灌洗液中的 T 细胞百分比更高。总之,通过副痘病毒 ORFV 载体传递来自 H1 IAV-S 亚型的共识 HA 减少了鼻分泌物中传染性病毒的脱落和 IAV-S 的病毒载量,并诱导了针对猪中不同流感病毒的细胞保护性免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/8f5ed4dc579e/viruses-15-00994-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/720dfcdfe702/viruses-15-00994-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/1b7324156588/viruses-15-00994-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/f28c65874e0f/viruses-15-00994-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/13ea835fcdc4/viruses-15-00994-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/3a5a5991c7d5/viruses-15-00994-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/9aa35ab5e89c/viruses-15-00994-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/90efe4ee6984/viruses-15-00994-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/69ec1d00bd99/viruses-15-00994-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/8f5ed4dc579e/viruses-15-00994-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/720dfcdfe702/viruses-15-00994-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/1b7324156588/viruses-15-00994-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/f28c65874e0f/viruses-15-00994-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/13ea835fcdc4/viruses-15-00994-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/3a5a5991c7d5/viruses-15-00994-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/9aa35ab5e89c/viruses-15-00994-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/90efe4ee6984/viruses-15-00994-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/69ec1d00bd99/viruses-15-00994-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa2f/10147081/8f5ed4dc579e/viruses-15-00994-g009.jpg

相似文献

1
An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses.基于口疮病毒(ORFV)的载体表达共识 H1 血凝素可提供针对多种猪流感病毒的保护。
Viruses. 2023 Apr 18;15(4):994. doi: 10.3390/v15040994.
2
Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus.ORF 病毒载体平台递送嵌合血凝素对猪流感病毒的免疫原性。
Front Immunol. 2024 Feb 28;15:1322879. doi: 10.3389/fimmu.2024.1322879. eCollection 2024.
3
Protective Efficacy of an Orf Virus-Vector Encoding the Hemagglutinin and the Nucleoprotein of Influenza A Virus in Swine.猪流感病毒血凝素和核蛋白基因重组口疮病毒载体疫苗的免疫保护效力。
Front Immunol. 2021 Nov 5;12:747574. doi: 10.3389/fimmu.2021.747574. eCollection 2021.
4
Antigenic Characterization and Pandemic Risk Assessment of North American H1 Influenza A Viruses Circulating in Swine.北美猪流感病毒的抗原特征和大流行风险评估。
Microbiol Spectr. 2022 Dec 21;10(6):e0178122. doi: 10.1128/spectrum.01781-22. Epub 2022 Nov 1.
5
Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses.脂质纳米颗粒包裹的 DNA 疫苗可预防猪源和人源 H1N1 流感病毒。
mSphere. 2024 Aug 28;9(8):e0028324. doi: 10.1128/msphere.00283-24. Epub 2024 Aug 1.
6
Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine.设计和鉴定针对猪源 H3 流感病毒的血凝素共识疫苗免疫原。
Vet Microbiol. 2019 Dec;239:108451. doi: 10.1016/j.vetmic.2019.108451. Epub 2019 Oct 12.
7
Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.改良安卡拉痘苗病毒表达的大流行(H1N1)2009 病毒血凝素诱导小鼠对欧亚“禽源样”H1N1 猪病毒产生交叉保护免疫。
Influenza Other Respir Viruses. 2014 May;8(3):367-75. doi: 10.1111/irv.12221. Epub 2013 Dec 23.
8
Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.四价神经氨酸酶 RNA 颗粒疫苗可保护猪免受同源和异源猪流感病毒感染。
Vaccine. 2023 Nov 13;41(47):6941-6951. doi: 10.1016/j.vaccine.2023.10.005. Epub 2023 Oct 24.
9
Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.用编码流感病毒血凝素的复制缺陷型5型腺病毒进行鼻内接种,可引发猪对同源攻击的保护性免疫,并对异源攻击产生部分保护作用。
Clin Vaccine Immunol. 2012 Nov;19(11):1722-9. doi: 10.1128/CVI.00315-12. Epub 2012 Aug 29.
10
Evolution and Antigenic Advancement of N2 Neuraminidase of Swine Influenza A Viruses Circulating in the United States following Two Separate Introductions from Human Seasonal Viruses.美国两种人季节性流感病毒传入后猪流感 A 病毒 N2 神经氨酸酶的进化和抗原性演变。
J Virol. 2021 Sep 27;95(20):e0063221. doi: 10.1128/JVI.00632-21. Epub 2021 Aug 11.

引用本文的文献

1
Advancing ORFV-Based Therapeutics to the Clinical Stage.将基于羊口疮病毒的疗法推进到临床阶段。
Rev Med Virol. 2025 May;35(3):e70038. doi: 10.1002/rmv.70038.
2
Efficacy of a Self-Vaccination Strategy for Influenza A Virus, , , and in Swine.甲型流感病毒……在猪群中的自我接种策略的效果
Vaccines (Basel). 2025 Feb 24;13(3):229. doi: 10.3390/vaccines13030229.
3
Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose-Chitosan Nanoparticle-Based Intranasal Vaccine in Swine.基于甘露糖-壳聚糖纳米颗粒的猪用鼻内疫苗中表面包被型与包囊型流感抗原的效力评估。

本文引用的文献

1
Protective Efficacy of an Orf Virus-Vector Encoding the Hemagglutinin and the Nucleoprotein of Influenza A Virus in Swine.猪流感病毒血凝素和核蛋白基因重组口疮病毒载体疫苗的免疫保护效力。
Front Immunol. 2021 Nov 5;12:747574. doi: 10.3389/fimmu.2021.747574. eCollection 2021.
2
Current and prospective control strategies of influenza A virus in swine.猪甲型流感病毒的当前及未来防控策略
Porcine Health Manag. 2021 Feb 28;7(1):23. doi: 10.1186/s40813-021-00196-0.
3
Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs.
Vaccines (Basel). 2024 Jun 11;12(6):647. doi: 10.3390/vaccines12060647.
4
Identification of an Immunodominant B-Cell Epitope in African Swine Fever Virus p30 Protein and Evidence of p30 Antibody-Mediated Antibody Dependent Cellular Cytotoxicity.鉴定非洲猪瘟病毒 p30 蛋白中的免疫显性 B 细胞表位及 p30 抗体介导的抗体依赖细胞细胞毒性的证据。
Viruses. 2024 May 10;16(5):758. doi: 10.3390/v16050758.
5
Swine influenza A virus: challenges and novel vaccine strategies.猪流感 A 病毒:挑战与新型疫苗策略。
Front Cell Infect Microbiol. 2024 Apr 3;14:1336013. doi: 10.3389/fcimb.2024.1336013. eCollection 2024.
6
Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus.ORF 病毒载体平台递送嵌合血凝素对猪流感病毒的免疫原性。
Front Immunol. 2024 Feb 28;15:1322879. doi: 10.3389/fimmu.2024.1322879. eCollection 2024.
7
Assessment of Immune Responses to a Trivalent Pichinde Virus-Vectored Vaccine Expressing Hemagglutinin Genes from Three Co-Circulating Influenza A Virus Subtypes in Pigs.评估猪对一种表达来自三种共同流行甲型流感病毒亚型血凝素基因的三价皮钦德病毒载体疫苗的免疫反应。
Vaccines (Basel). 2023 Dec 2;11(12):1806. doi: 10.3390/vaccines11121806.
8
Increased Fungal Infection Mortality Induced by Concurrent Viral Cellular Manipulations.病毒对细胞的操纵会增加真菌感染死亡率。
Lung. 2023 Oct;201(5):467-476. doi: 10.1007/s00408-023-00642-6. Epub 2023 Sep 5.
鼻腔内递送灭活流感病毒和聚肌胞吸附于玉米来源纳米颗粒疫苗可在母源抗体阳性仔猪中诱导强烈的抗原特异性细胞介导免疫应答。
Front Immunol. 2020 Dec 16;11:596964. doi: 10.3389/fimmu.2020.596964. eCollection 2020.
4
Swine influenza virus: Current status and challenge.猪流感病毒:现状与挑战。
Virus Res. 2020 Oct 15;288:198118. doi: 10.1016/j.virusres.2020.198118. Epub 2020 Aug 13.
5
Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.携带2009年大流行病毒基因、易使人感染的常见欧亚禽源样H1N1猪流感病毒。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17204-17210. doi: 10.1073/pnas.1921186117. Epub 2020 Jun 29.
6
Evolution and Pathogenicity of the H1 and H3 Subtypes of Swine Influenza Virus in Mice between 2016 and 2019 in China.2016 年至 2019 年中国小鼠中流感病毒 H1 和 H3 亚型的进化和致病性。
Viruses. 2020 Mar 9;12(3):298. doi: 10.3390/v12030298.
7
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.大流行性流感病毒疫苗可增强成年和儿童接种者体内血凝素茎特异性抗体反应。
NPJ Vaccines. 2019 Dec 6;4:51. doi: 10.1038/s41541-019-0147-z. eCollection 2019.
8
Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine.设计和鉴定针对猪源 H3 流感病毒的血凝素共识疫苗免疫原。
Vet Microbiol. 2019 Dec;239:108451. doi: 10.1016/j.vetmic.2019.108451. Epub 2019 Oct 12.
9
Bidirectional Human-Swine Transmission of Seasonal Influenza A(H1N1)pdm09 Virus in Pig Herd, France, 2018.2018 年法国猪群中季节性流感 A(H1N1)pdm09 病毒的双向人际传播。
Emerg Infect Dis. 2019 Oct;25(10):1940-1943. doi: 10.3201/eid2510.190068.
10
Amish (Rural) vs. non-Amish (Urban) Infant Fecal Microbiotas Are Highly Diverse and Their Transplantation Lead to Differences in Mucosal Immune Maturation in a Humanized Germfree Piglet Model.阿米什(农村)与非阿米什(城市)婴儿粪便微生物群高度多样化,其移植可导致人源化无菌猪模型中黏膜免疫成熟的差异。
Front Immunol. 2019 Jul 16;10:1509. doi: 10.3389/fimmu.2019.01509. eCollection 2019.